EAU 2025 | Evaluating the four-tier hybrid grading system in Ta NMIBC

Ludovica Cella • 21 Mar 2025

EAU 2025

Ludovica Cella, MD, Humanitas University, Milan, Italy, discusses findings from a study assessing the prognostic performance of a four-tier hybrid grading system in Ta non–muscle-invasive bladder cancer (NMIBC). By integrating elements of the WHO 1973 and 2004 classifications, this hybrid approach demonstrated enhanced ability to differentiate patient outcomes related to disease progression and recurrence. These findings support its value in improving diagnostic clarity and informing tailored management strategies in NMIBC. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.